Anti-ACAA2 antibody [EPR6732(2)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal ACAA2 antibody. Suitable for IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 5 publications.
View Alternative Names
Acetyl-CoA acetyltransferase, Acetyl-CoA acyltransferase, Beta-ketothiolase, Mitochondrial 3-oxoacyl-CoA thiolase, T1, ACAA2
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ACAA2 antibody [EPR6732(2)] (AB128929)
ab128929, at a 1/50 dilution, staining Human ACAA2 in kidney, using Immunohistochemistry, Formalin/PFA-fixed paraffin-emebedded tissue.
Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-ACAA2 antibody [EPR6732(2)] (AB128929)
ab128929, at a 1/250 dilution, staining Human ACAA2 in HepG2 cells, using Immunofluorescence.
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-ACAA2 antibody [EPR6732(2)] (AB128929)
Flow Cytometry analysis of RPMI-8226 (Human plasmacytoma, myeloma B Lymphocyte) cells labeling ACAA2 with purified ab128929 at 1/100 dilution (10 μg/mL) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
- WB
Unknown
Western blot - Anti-ACAA2 antibody [EPR6732(2)] (AB128929)
All lanes:
Western blot - Anti-ACAA2 antibody [EPR6732(2)] (ab128929) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
Caco-2 cell lysate at 10 µg
Lane 3:
HepG2 cell lysate at 10 µg
Secondary
All lanes:
HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 41 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-ACAA2 antibody [EPR6732(2)] (AB128929)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
- WB
CiteAb
Western blot - Anti-ACAA2 antibody [EPR6732(2)] (AB128929)
ACAA2 western blot using anti-ACAA2 antibody [EPR6732(2)] ab128929. Publication image and figure legend from Zhang, Y. K., Qu, Y. Y., et al., 2017, Nat Commun, PubMed 28878358.
ab128929 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab128929 please see the product overview.
ECHS1 protein levels are decreased by nutrients. a Schematic diagram of catabolic pathways of FA (black-colored) and BCAA (red-colored) oxidation that involve ECHS1. Long chain FAs are oxidized to short-chained intermediates prior to being completely oxidized through ECHS1. BCAAs are oxidized through ECHS1. ACADL acyl-CoA dehydrogenase, long chain, ACADM medium-chain specific acyl-CoA dehydrogenase, mitochondrial, ACADS short-chain specific acyl-CoA dehydrogenase, ACSL acyl-CoA synthetase long-chain, BCAT branched-chain amino-acid transaminase, BCKDH branched-chain keto acid dehydrogenase, carnitine palmitoyltransferase, ECHS1 enoyl CoA hydratase, short chain 1, mitochondrial, EHHADH Enoyl-CoA, Hydratase/3-Hydroxyacyl CoA Dehydrogenase. b–d Endogenous ECHS1 levels were detected in HEK293T cells treated with different concentrations of glucose (b), FAs (linoleic acid + palmitic acid) (c), and amino acids (glutamate + aspartate) (d). Representative western blot results and quantitation (herein after) of triplicated western blot are shown. e HepG2 cells were exposed to indicated concentrations of glucose. Levels of endogenous β-oxidation enzymes were detected 4 h after glucose exposure. CPT1A Carnitine O-palmitoyltransferase 1, liver isoform, Carnitine O-palmitoyltransferase 2, mitochondrial, HADHA Trifunctional enzyme subunit alpha, mitochondrial, ACAA2 3-ketoacyl-CoA thiolase, mitochondrial. f Plasma ECHS1 levels of normal people (blue, n = 14) and untreated patients with diabetes (red, n = 12) were determined by western blots. Relative ECHS1 levels (normalized to the average ECHS1 level) were plotted against serum glucose levels. g Mitochondria of HEK293T cells cultured in DMEM base, DMEM base supplemented with glucose (25 mM), fatty acids (250 nM) and amino acids (8 mM), respectively, were isolated and the relative (to SOD2 and TOM40) mitochondrial ECHS1 levels were compared. For b–d, mean values of quantitation with SD are reported. *p < 0.05; **p < 0.01; ***p < 0.001
false
Related conjugates and formulations (1)
-
Anti-ACAA2 antibody [EPR6732(2)] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The enzyme catalyzes reactions in energy metabolism by breaking down fatty acids to generate energy. ACAA2 functions as part of the complex mitochondrial fatty acid beta-oxidation machinery. This process supports energy production particularly under conditions of carbohydrate depletion. The production of acetyl-CoA by ACAA2 is important for the TCA cycle through which cells generate ATP the primary energy carrier.
Pathways
Acetyl-CoA acyltransferase 2 plays significant roles in both the fatty acid beta-oxidation and ketogenesis pathways. In the beta-oxidation pathway it works together with other enzymes like CPT1A and HADHB to efficiently break down fatty acids. In ketogenesis acetyl-CoA units produced by ACAA2 are directed towards the formation of ketone bodies which serve as an alternative energy source for the brain and muscles during fasting or prolonged exercise.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Scientific reports 15:20507 PubMed40592997
2025
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 129:1818-1828 PubMed37798372
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of hepatocellular carcinoma 10:1327-1339 PubMed37581093
2023
Applications
Unspecified application
Species
Unspecified reactive species
Acta biochimica et biophysica Sinica 55:1467-1478 PubMed37310146
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 8:464 PubMed28878358
2017
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com